PatientsVille.com Logo

PatientsVille

Perdipine Side Effects

Common Perdipine Side Effects


The most commonly reported Perdipine side effects (click to view or check a box to report):

Cerebral Haemorrhage (6)
Abdominal Pain (5)
Bile Duct Stone (5)
Blood Lactate Dehydrogenase Increased (5)
Alanine Aminotransferase Increased (5)
Aspartate Aminotransferase Increased (5)
Blood Alkaline Phosphatase Increased (4)
Back Pain (4)
Stevens-johnson Syndrome (4)
Purpura (3)
Bile Duct Obstruction (3)
Toxic Skin Eruption (3)
Cholelithiasis (3)
Blood Creatinine Increased (3)
Erythema Multiforme (3)
Blood Pressure Inadequately Controlled (3)
Disseminated Intravascular Coagulation (2)
Rash (2)
Blood Bilirubin Increased (2)
Papuloerythroderma Of Ofuji (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Perdipine Side Effects Reported to FDA

The following Perdipine reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Perdipine on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Febrile Neutropenia
This is a report of a 70-year-old male patient (weight: NA) from JP, suffering from the following symptoms/conditions: NA, who was treated with Perdipine (dosage: NA, start time: Feb 15, 2012), combined with:
  • Modacin
  • Lasix
  • Linton
  • Rocephin
  • Ropion
  • Rohypnol
  • Vidaza (75 Milligram/sq. Meter)
  • Vidaza (37.5 Milligram/sq. Meter)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Febrile Neutropenia
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Perdipine treatment in male patients, resulting in febrile neutropenia side effect.

Gastric Cancer
This report suggests a potential Perdipine-la Gastric Cancer side effect(s) that can have serious consequences. A male patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: NA and used Perdipine-la (dosage: NA) starting Jul 02, 2001. Soon after starting Perdipine-la the patient began experiencing various side effects, including:
  • Gastric Cancer
Drugs used concurrently:
  • Diovan (40 Mg, Qd)
  • Myonal
  • Phenytoin
  • Phenobal
  • Juvela
The patient was hospitalized. Although Perdipine-la demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as gastric cancer, may still occur.

Haemorrhagic Infarction, Septic Shock
This Haemorrhagic Infarction, Septic Shock problem was reported by a physician from JAPAN. A 76-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: hypertension,thrombotic cerebral infarction. On Feb 14, 2011 this consumer started treatment with Perdipine (dosage: 120 Mg, Unk). The following drugs were being taken at the same time:
  • Argatroban (60 Mg, Daily)
  • Grtpa (34.8 Ml, 1x/day)
  • Herbesser (240 Mg, Unk)
  • Carbazochrome Sodium Sulfonate (100 Mg, Unk)
  • Inovan (450 Mg, Unk)
  • Pitressin (5 Ut)
  • Glyceol (400 Ml, Unk)
  • Nitrazepam (72 Mg, Unk)
When commencing Perdipine, the patient experienced the following unwanted symptoms/side effects:
  • Haemorrhagic Infarction
  • Septic Shock
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as haemorrhagic infarction, may become evident only after a product is in use by the general population.

Melaena
This is a report of a 79-year-old female patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: angina pectoris,gastric ulcer,platelet count increased,polycythaemia vera,polyuria and was treated with Perdipine (dosage: NA) starting Jan 01, 1993. Concurrently used drugs:
  • Mucosta
  • Bufferin Lion Tabs 81 Mg
  • Hydrea
  • Aldactone
Soon after that, the consumer experienced the following side effects:
  • Melaena
The patient was hospitalized. This opens a possibility that Perdipine treatment could cause the above reactions, including melaena, and some female subjects may be more susceptible.


Stomatitis, Rash, Hepatic Failure, Blood Creatinine Increased, Blood Bilirubin Increased
A female patient (weight: NA) from JAPAN with the following symptoms/conditions: NA started Perdipine treatment (dosage: Daily Dose 60 Mg) on Nov 26, 2010. Soon after starting Perdipine treatment, the subject experienced various side effects, including:
  • Stomatitis
  • Rash
  • Hepatic Failure
  • Blood Creatinine Increased
  • Blood Bilirubin Increased
Concurrently used drugs:
  • Nexavar (Daily Dose 800 Mg)
  • Nu Lotan (Daily Dose 50 Mg)
  • Lasix (Daily Dose 20 Mg)
  • Nexavar (Daily Dose 400 Mg)
  • Loxonin (Daily Dose 120 Mg)
  • Omepral (Daily Dose 20 Mg)
  • Depas (Daily Dose 1 Mg)
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Perdipine.

Stomatitis, Blood Bilirubin Increased, Blood Creatinine Increased, Hepatic Failure, Rash
A female patient from JAPAN (weight: NA) experienced symptoms, such as: NA and was treated with Perdipine(dosage: Daily Dose 60 Mg). The treatment was initiated on Nov 26, 2010. After that a consumer reported the following side effect(s):
  • Stomatitis
  • Blood Bilirubin Increased
  • Blood Creatinine Increased
  • Hepatic Failure
  • Rash
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Perdipine efficacy:
  • Omepral (Daily Dose 20 Mg)
  • Nu Lotan (Daily Dose 50 Mg)
  • Nexavar (Daily Dose 800 Mg)
  • Nexavar (Daily Dose 400 Mg)
  • Loxonin (Daily Dose 120 Mg)
  • Lasix (Daily Dose 20 Mg)
  • Depas (Daily Dose 1 Mg)
The patient was hospitalized.

Putamen Haemorrhage, Loss Of Consciousness
In this report, Perdipine was administered for the following condition: NA.A male consumer from JAPAN (weight: NA) started Perdipine treatment (dosage: NA) on Aug 07, 2009.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Putamen Haemorrhage
  • Loss Of Consciousness
A possible interaction with other drugs could have contributed to this reaction:
  • Norvasc (Dosage Was Uncertain.)
  • Levofolinate
  • Granisetron Hcl
  • Decadron
  • Blopress (Dosage Is Uncertain)
  • Fluorouracil
  • Nitroderm (Form Reported As: Tape)
  • Glufast (Dosage Is Uncertain)
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Perdipine treatment could be related to the listed above side effect(s).

Dysgeusia, Blood Creatine Phosphokinase Increased, Nausea
This is a report of the following Perdipine side effect(s):
  • Dysgeusia
  • Blood Creatine Phosphokinase Increased
  • Nausea
A 47-year-old male patient from JAPAN (weight: NA) presented with the following condition: NA and received a treatment with Perdipine (dosage: 20 Mg/day) starting: Oct 09, 2010.The following concurrently used drugs could have generated interactions:
  • Depas (0.5 Mg/day)
  • Champix (1 Mg/day)
This report suggests that a Perdipine treatment could be associated with the listed above side effect(s).

Blood Creatinine Increased, Blood Pressure Decreased, Blood Urea Increased, Renal Failure Acute, Urine Output Decreased
This Perdipine report was submitted by a 45-year-old male consumer from JAPAN (weight: NA). The patient was diagnosed with: hypertension and Perdipine was administered (dosage: NA) starting: NS. The consumer developed a set of symptoms:
  • Blood Creatinine Increased
  • Blood Pressure Decreased
  • Blood Urea Increased
  • Renal Failure Acute
  • Urine Output Decreased
Other drugs used simultaneously:
  • Voltaren (50 Mg, Unk)
  • Calblock (16 Mg Daily, Unk)
  • Olmetec (20 Mg Daily, Unk)
  • Thiamylal
  • Phenobal
Those unexpected symptoms could be linked to a Perdipine treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Papuloerythroderma Of Ofuji
This is a report of a possible correlation between Perdipine use and the following symptoms/side effect(s):
  • Papuloerythroderma Of Ofuji
which could contribute to an assessment of Perdipine risk profile.A 60-year-old male consumer from JAPAN (weight: NA) was suffering from renal hypertension and was treated with Perdipine (dosage: NA) starting May 01, 1987.Other concurrent medications:
  • Emaberin
  • Fluitran


Papuloerythroderma Of Ofuji
A 60-year-old male patient from JAPAN (weight: NA) presented with the following symptoms: renal hypertension and after a treatment with Perdipine (dosage: NA) experienced the following side effect(s):
  • Papuloerythroderma Of Ofuji
The treatment was started on May 01, 1987. Perdipine was used in combination with the following drugs:
  • Emaberin
  • Fluitran
This report could alert potential Perdipine consumers.

Cerebral Haemorrhage
In this report, a male patient from JAPAN (weight: NA) was affected by a possible Perdipine side effect.The patient was diagnosed with hypertension,stomatitis,diarrhoea,abdominal pain upper,nausea,constipation. After a treatment with Perdipine (dosage: Unk, start date: Feb 01, 2008), the patient experienced the following side effect(s):
  • Cerebral Haemorrhage
The following simultaneously used drugs could have led to this reaction:
  • Dexaltin (Unk)
  • Lopemin (Unk)
  • Omeprazole (20 Mg)
  • Sm (1 Df)
  • Maglax (Unk)
  • Glysennid (Unk)
  • Loxonin (Unk)
  • Mucosta (Unk)
The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Perdipine treatment.

Cerebral Haemorrhage
This is a report of a male patient from JAPAN (weight: NA), who used Perdipine (dosage: Unk) for a treatment of hypertension,stomatitis,diarrhoea,abdominal pain upper,nausea,constipation. After starting a treatment on Feb 01, 2008, the patient experienced the following side effect(s):
  • Cerebral Haemorrhage
The following drugs could possibly have interacted with the Perdipine treatment
  • Dexaltin (Unk)
  • Lopemin (Unk)
  • Omepral (20 Mg)
  • Sm (1 Df)
  • Maglax (Unk)
  • Glysennid (Unk)
  • Loxonin (Unk)
  • Mucosta (Unk)
The patient was hospitalized.Taken together, these observations suggest that a Perdipine treatment could be related to side effect(s), such as Cerebral Haemorrhage.

Cerebral Haemorrhage
This cerebral haemorrhage side effect was reported by a physician from JAPAN. A male patient (weight:NA) experienced the following symptoms/conditions: hypertension,stomatitis,diarrhoea,abdominal pain upper,nausea,constipation. The patient was prescribed Perdipine (dosage: Unk), which was started on Feb 01, 2008. Concurrently used drugs:
  • Dexaltin (Unk)
  • Lopemin (Unk)
  • Omepral (20 Mg)
  • Sm (1 Df)
  • Maglax (Unk)
  • Glysennid (Unk)
  • Loxonin (Unk)
  • Mucosta (Unk)
When starting to take Perdipine the consumer reported the following symptoms:
  • Cerebral Haemorrhage
The patient was hospitalized. These side effects may potentially be related to Perdipine.

Cerebral Haemorrhage
This is a Perdipine side effect report of a male patient (weight:NA) from JAPAN, suffering from the following symptoms/conditions: hypertension,stomatitis,diarrhoea,abdominal pain upper,nausea,constipation, who was treated with Perdipine (dosage:NA, start time: Feb 01, 2008), combined with:
  • Dexaltin
  • Lopemin
  • Omepral (20 Mg)
  • Sm (1.3 G)
  • Maglax
  • Glysennid
  • Loxonin
  • Mucosta
, and developed a serious reaction and a cerebral haemorrhage side effect. The patient presented with:
  • Cerebral Haemorrhage
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Perdipine treatment in male patients suffering from hypertension,stomatitis,diarrhoea,abdominal pain upper,nausea,constipation, resulting in cerebral haemorrhage.

Stevens-johnson Syndrome
This report suggests a potential Perdipine stevens-johnson syndrome side effect(s) that can have serious consequences. A 70-year-old male patient from JAPAN (weight:NA) was diagnosed with the following health condition(s): hypertension,pyrexia and used Perdipine (dosage: Daily Dose Reported: Increased Or Decreased Based On Blood Pressure, On An As Needed Basis.) starting Sep 25, 2006. Soon after starting Perdipine the patient began experiencing various side effects, including:
  • Stevens-johnson Syndrome
Drugs used concurrently:
  • Naproxen
  • Rohypnol
  • Rohypnol
  • Rohypnol
  • Rohypnol
  • Cercine
  • Myslee
  • Myslee
Although Perdipine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as stevens-johnson syndrome, may still occur.

Stevens-johnson Syndrome
This stevens-johnson syndrome problem was reported by a physician from JAPAN. A 70-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): hypertension,pyrexia.On Sep 25, 2006 a consumer started treatment with Perdipine (dosage: Daily Dose Reported: Increased Or Decreased Based On Blood Pressure, On An As Needed Basis.). The following drugs/medications were being taken at the same time:
  • Naproxen
  • Rohypnol
  • Rohypnol
  • Rohypnol
  • Rohypnol
  • Cercine
  • Myslee
  • Myslee
When commencing Perdipine, the patient experienced the following unwanted symptoms /side effects:
  • Stevens-johnson Syndrome
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as stevens-johnson syndrome, may become evident only after a product is in use by the general population.

Stevens-johnson Syndrome
This is a Perdipine side effect report of a 70-year-old male patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: hypertension,pyrexia and was treated with Perdipine (dosage: Daily Dose Reported: Increased Or Decreased Based On Blood Pressure, On An As Needed Basis.) starting Sep 25, 2006. Concurrently used drugs:
  • Naproxen
  • Rohypnol
  • Rohypnol
  • Rohypnol
  • Rohypnol
  • Cercine
  • Myslee
  • Myslee
Soon after that, the consumer experienced the following of symptoms:
  • Stevens-johnson Syndrome
This opens a possibility that Perdipine could cause stevens-johnson syndrome and that some male patients may be more susceptible.

Stevens-johnson Syndrome
A 70-year-old male patient (weight: NA) from JAPAN with the following symptoms: hypertension,pyrexia started Perdipine treatment (dosage: Daily Dose Reported: Increased Or Decreased Based On Blood Pressure, On An As Needed Basis.) on Sep 25, 2006. Soon after starting Perdipine treatment, the consumer experienced several side effects, including:
  • Stevens-johnson Syndrome
. Concurrently used drugs:
  • Naproxen
  • Rohypnol
  • Rohypnol
  • Rohypnol
  • Rohypnol
  • Cercine
  • Myslee
  • Myslee
This finding indicates that some patients can be more vulnerable to developing Perdipine side effects, such as stevens-johnson syndrome.

Abdominal Pain, Disseminated Intravascular Coagulation, Inflammatory Bowel Disease
This abdominal pain side effect was reported by a physician from JAPAN. A 29-year-old male patient (weight:NA) experienced the following symptoms/conditions: hypertension.The patient was prescribed Perdipine (dosage: Dose Reported As 96 Mg Continuous; 4 Ml/hour), which was started on Mar 06, 2007. Concurrently used drugs:
  • Norvasc
  • Nu-lotan
.When starting to take Perdipine the consumer reported symptoms, such as:
  • Abdominal Pain
  • Disseminated Intravascular Coagulation
  • Inflammatory Bowel Disease
These side effects may potentially be related to Perdipine.

Ileus Paralytic
This is a report of a 68-year-old male patient (weight: NA) from JAPAN, suffering from the following symptoms/conditions: blood pressure management, who was treated with Perdipine (dosage: Duration:14 Hrs 55 Min: 24 July 2006, 1.35 P.m. 2.0 Ml/hr, 2:00 P.m. Increased To 3.0 Ml/hr, 5:00 P+, start time: Jul 18, 2006), combined with:
  • Atropine Sulfate
  • Clarithromycin
and developed a serious reaction and side effect(s). The consumer presented with:
  • Ileus Paralytic
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Perdipine treatment in male patients, resulting in ileus paralytic side effect. The patient was hospitalized.

Abdominal Pain, Bacteraemia, Disseminated Intravascular Coagulation, Haemodialysis, Inflammatory Bowel Disease
This report suggests a potential Perdipine Abdominal Pain, Bacteraemia, Disseminated Intravascular Coagulation, Haemodialysis, Inflammatory Bowel Disease side effect(s) that can have serious consequences. A 29-year-old male patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: hypertension and used Perdipine (dosage: 120 Ml Daily) starting Mar 06, 2007. Soon after starting Perdipine the patient began experiencing various side effects, including:
  • Abdominal Pain
  • Bacteraemia
  • Disseminated Intravascular Coagulation
  • Haemodialysis
  • Inflammatory Bowel Disease
Drugs used concurrently:
  • Norvasc
  • Nu-lotan
Although Perdipine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as abdominal pain, may still occur.

Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Erythema Multiforme, Hepatic Function Abnormal, Purpura
This Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Erythema Multiforme, Hepatic Function Abnormal, Purpura problem was reported by a physician from JAPAN. A 64-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: hypertension,hypercholesterolaemia. On Apr 18, 2005 this consumer started treatment with Perdipine (dosage: NA). The following drugs were being taken at the same time:
  • Lipitor (Dosage Regimen Reported As 10 Mg, Uid/qd.)
  • Mucosta
  • Toughmac E
  • Takepron
When commencing Perdipine, the patient experienced the following unwanted symptoms/side effects:
  • Alanine Aminotransferase Increased
  • Aspartate Aminotransferase Increased
  • Blood Lactate Dehydrogenase Increased
  • Erythema Multiforme
  • Hepatic Function Abnormal
  • Purpura
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as alanine aminotransferase increased, may become evident only after a product is in use by the general population.

Erythema Multiforme, Hepatic Function Abnormal, Purpura
This is a report of a 64-year-old female patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: hypertension,hypercholesterolaemia and was treated with Perdipine (dosage: NA) starting Apr 18, 2006. Concurrently used drugs:
  • Lipitor (Dosage Regimen Reported As 10 Mg, Uid/qd.)
  • Mucosta
  • Toughmac E
  • Takepron
Soon after that, the consumer experienced the following side effects:
  • Erythema Multiforme
  • Hepatic Function Abnormal
  • Purpura
The patient was hospitalized. This opens a possibility that Perdipine treatment could cause the above reactions, including erythema multiforme, and some female subjects may be more susceptible.

Cerebral Decompression, Depressed Level Of Consciousness, Headache, Hemiplegia, Intra-cerebral Aneurysm Operation, Respiratory Disorder, Subarachnoid Haemorrhage, Ventriculo-peritoneal Shunt
A 56-year-old female patient (weight: NA) from JAPAN with the following symptoms/conditions: hypertension,hyperthyroidism,hypercholesterolaemia started Perdipine treatment (dosage: 40 Mg, Unk) on Mar 05, 2003. Soon after starting Perdipine treatment, the subject experienced various side effects, including:
  • Cerebral Decompression
  • Depressed Level Of Consciousness
  • Headache
  • Hemiplegia
  • Intra-cerebral Aneurysm Operation
  • Respiratory Disorder
  • Subarachnoid Haemorrhage
  • Ventriculo-peritoneal Shunt
Concurrently used drugs:
  • Thyradin S
  • Mevalotin
  • Diovan (40 Mg, Qd)
The patient was hospitalized and became disabled. This finding indicates that some female patients could be more vulnerable to Perdipine.

1 of 2 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Perdipine Side Effects

    Did You Have a Perdipine Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Perdipine for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Perdipine Safety Alerts, Active Ingredients, Usage Information

    More About Perdipine

    Side Effects reported to FDA: 39

    Perdipine safety alerts: No

    Reported deaths: 8

    Reported hospitalizations: 20

    Latest Perdipine clinical trials

    Perdipine Reviews

    No reviews, be a first to report a side effect via side effect reporting form